Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Completed · Phase 1

Conditions studied: Cancer

In brief

RATIONALE: When irradiated lymphocytes from a donor are infused into the patient they may help the patient's immune system kill cancer cells. PURPOSE: This pilot study is looking at the side effects and how well irradiated donor lymphocyte infusion works in treating patients with relapsed or refractory hematologic cancer or solid tumor.

Key facts

Study ID

NCT00161187

Run by

University of Medicine and Dentistry of New Jersey

People needed

37

Starts

2001-05-01

Expected to finish

2011-10-01

Last updated by the study team

2015-11-06

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.